Vetoquinol - Universal Registration Document - 2021

CONSOLIDATED FINANCIAL STATEMENTS Notes to the consolidated financial statements Vetoquinol Universal Registration Document 2020 Financial report 83 6 Impact on financial statements (€000) IFRS 16 balance sheet impact Dec 31, 2020 Dec 31, 2019 Pre-IFRS 16 non-current assets 326,778 243,763 Right-of-use assets (leases) 12,150 10,386 POST-IFRS 16 NON-CURRENT ASSETS 338,928 254,148 Pre-IFRS 16 current liabilities 235,179 88,329 Lease liabilities due in less than one year 4,371 4,377 POST-IFRS 16 CURRENT LIABILITIES 239,550 92,706 Pre-IFRS 16 non-current liabilities 26,636 26,480 Lease liabilities due in over one year 8,077 6,300 POST-IFRS 16 NON-CURRENT LIABILITIES 34,713 32,781 INCOME STATEMENT - IFRS 16 IMPACT 2020 2019 Pre-IFRS 16 other purchases and external expenses (87,856) (86,380) Canceled rent payments 5,039 4,938 POST-IFRS 16 EXTERNAL EXPENSES (82,818) (81,442) Pre-IFRS 16 depreciation and impairment of fixed assets (11,871) (11,522) Depreciation and impairment of fixed assets - IFRS 16 impact (4,905) (4,792) POST-IFRS 16 DEPRECIATION AND IMPAIRMENT OF FIXED ASSETS (16,775) (16,314) Pre-IFRS 16 gross cost of debt (693) (217) Interest paid - Lease liabilities (134) (165) POST-IFRS 16 GROSS COST OF DEBT (828) (382) Pre-IFRS 16 income tax expense (16,635) (12,464) Deferred tax - IFRS 16 impact - - POST-IFRS 16 INCOME TAX EXPENSE (16,635) (12,464) TOTAL IMPACT ON INCOME STATEMENT (0) (18) 6.5.16 EBITDA €000 2020 2019 Operating income 37,095 40,886 Provisions and write-backs recorded under non-recurring operating income and expenses 19,524 4,372 Provisions and write-backs 1,407 876 Depreciation and impairment of fixed assets 20,975 14,504 Depreciation and impairment of fixed assets - IFRS 16 4,905 4,792 EBITDA 83,905 65,429 % of sales 19.6% 16.5%